Driver safety, globally
Tailoring a global vision, standards, objectives and content to local need.
With a 150+ year history, Pfizer Inc. is one of the world’s leading pharmaceutical and healthcare companies, represented in over 70 countries by approximately 100,000 colleagues – approximately one third of whom comprise the sales organization who need to travel to engage with key groups such as distributors and medical professionals.
Globally Pfizer operates over 33,200 company cars and 3,500 motorcycles, for which a standardized world-wide fleet safety program has been developed. Additionally, Pfizer has hundreds of site vehicles including trucks, vans and motorized equipment. Driving has been identified as one of the most hazardous activities colleagues undertake. Accordingly, continuous assessment and improvement of Pfizer’s global fleet safety effort is a high priority for the safety of colleagues and others in the communities in which we operate.
Transforming road-related risk
Pfizer’s global fleet safety program was launched internationally in 2010, based on a three phased implementation period and has reached an initial launch of 80% of our fleet in 23 countries.
The key elements of the program are:
- Vehicle selection / maintenance.
- Risk ranking.
- Communication of results and targeted training / driver coaching.
- On-going encouragement and support.
- Assessing, communicating and coaching the expected behaviors for Pfizer drivers.
The program is supported by a customized data management system to track and trend driving performance which has the ability to identify needs for additional supervision or coaching. The program proceeds with the following online and face to face modules accessed globally via Virtual Risk Manager (VRM).
Review and execution of Privacy Consent, Local Policy Acknowledgement, and Pfizer Safe Driving Pledge; along with completion of the Pfizer Safe Driver Risk Foundation module which seeks to ensure knowledge and understanding of the local policy and driver minimum performance criteria, along with a ‘Rules of the Road Best Practice Guide’.
Completion of online RoadRISK tool to assess driver exposures and behaviours.
Completion of awareness coaching and for identified at high risk drivers – based on VRM DriverINDEX and OneToOne Manager / Driver coaching sessions.
Completion of country specific ‘gap analysis’ to re-evaluate the effectiveness of and set goals to continuously improve the program.
Following program launch and annually thereafter, all participants are required to refresh the Safe Driving Pledge and Safe Driver Risk Foundation questionnaire via VRM; repeat the risk ranking process with a year on year comparison; continue awareness coaching selected from a range of appropriate online and face to face modules. The data is reviewed to identify at medium and at high risk drivers, who are then provided with additional coaching as required based on local market decisions.
Supporting the program, the Global Fleet Safety Implementation Team is comprised of a Project Leader / Champion, Fleet Senior Director, Regional Fleet Directors, Director / Team Leader EHS, Global Privacy Office and Human Resource, Global Risk Insurance.
The Pfizer fleet safety program is innovative in its partnership-based approach and the detailed multi-lingual tools, management information system and data warehouse developed to support global, regional and business unit managers in their decision making. This approach has assisted in the successful replication of a globally consistent process, with modifications as required to address specific local needs.